Hester Biosciences Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2015. For the quarter, the company reported net sales/income from operations of INR 241.77 million compared to INR 218.83 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 62.66 million compared to INR 54.77 million a year ago. Profit from ordinary activities before tax was INR 59.30 million compared to INR 45.36 million a year ago. Net profit from ordinary activities after tax was INR 47.58 million or INR 5.59 per basic and diluted share before and after extraordinary items not annualized compared to INR 33.71 million or INR 3.96 per basic and diluted share before and after extraordinary items not annualized a year ago.

For the nine months, the company reported net sales/income from operations of INR 727.11 million compared to INR 666.76 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 192.60 million compared to INR 165.90 million a year ago. Profit from ordinary activities before tax was INR 174.84 million compared to INR 136.23 million a year ago. Net profit from ordinary activities after tax was INR 137.18 million or INR 16.13 per basic and diluted share before and after extraordinary items not annualized compared to INR 104.55 million or INR 12.29 per basic and diluted share before and after extraordinary items not annualized a year ago.